Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$0.75
>-$0.01(-1.38%)
At close: 4:00 PM EDT
$0.75
>-$0.01(-1.38%)
Day’s Range― - ―
52-Week Range$0.61 - $4.35
Previous Close$0.69
Volume106.08K
Average Volume (3M)229.06K
Market Cap
$130.69M
Enterprise Value$114.59
Total Cash (Recent Filing)$183.59M
Total Debt (Recent Filing)$167.06M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Nov 05, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.60
Shares Outstanding106,744,710
10 Day Avg. Volume299,630
30 Day Avg. Volume229,064
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$1.70Price Target Upside126.67% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)0.2
Revenue Forecast (FY)$221.23M
Bulls Say, Bears Say
Bulls Say
Recurring Healthcare Data SubscriptionsSubscription-based access to curated healthcare intelligence can create recurring revenue and embed the product in customer workflows. Continuous data updates, add-on modules and renewal potential support durable customer relationships and expansion.
Strong Cash Generation And Improved LeveragePositive free cash flow despite reported losses provides internal funding for operations and product investment. Sharply improved leverage also increases financial flexibility, helping the company manage through slower growth without relying as heavily on external capital.
Product Integration And AI ExpansionFaster integrations reduce customer adoption friction and can strengthen workflow embedment, renewals and expansion. Turbo and broader AI functionality create additional product differentiation and longer-term opportunities to improve retention and platform relevance.
Bears Say
Persistent Revenue ContractionSustained top-line contraction indicates weaker demand or reduced customer spending across important markets. Continued declines can limit operating leverage, reduce resources for product investment and make a durable return to growth more difficult.
Lower Forward Revenue VisibilityLower RPO and shorter contract durations reduce committed future revenue and make renewal outcomes more important. This weakens planning visibility, increases exposure to annual budget decisions and may constrain the durability of recurring revenue.
Persistent Net Losses And Weak ReturnsStrong gross margins have not yet translated into consistent GAAP profitability, indicating that operating and other costs remain burdensome. Persistent losses weaken retained capital and reduce the balance-sheet cushion available to absorb further revenue pressure.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.61 and its highest was $4.35 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $130.69M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Nov 05, 2026 which is in 63 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Aug 10, 2026. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.043 by $0.007.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.04.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 106,744,710 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.05 in its last earnings report, beating expectations of $0.043. Following the earnings report the stock price went down -7.88%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.70 (126.67% Upside)
$1.70 (126.67% Upside)
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.70%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-35.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a balanced message: clear near‑term top‑line pressures (Q2 revenue down 9% YoY, RPO and deferred revenue down double digits, professional services softness, and continued life sciences drag) alongside strong profitability, disciplined cost management, robust free cash flow (~$50M TTM), operational progress (integrations, win‑backs, digital activation growth), and product/AI momentum (Turbo pilot and AI embedding). Management tightened full‑year revenue guidance while raising profit/margin guidance and emphasized that improvements in net dollar retention and customer win‑backs underpin confidence in a return to growth over time.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$1.70
▲(126.67% Upside)
Technical Analysis
Ownership Overview
11.16% Insiders
3.81% Mutual Funds
61.67% Other Institutional Investors
19.04% Public Companies and
Individual Investors